LEXX Financials
Lexaria Bioscience Corp - Financial statements & key metrics
Stock Price
$1.03
Market Cap
$24.42M
EPS
$-0.47
Income Statement Highlights
Most Recent Quarter: 2025-08-31
Revenue
$705923.00
Gross Profit
$587351.00
Operating Income
$-11.63M
Net Income
$-11.90M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$4.18M
Total Liabilities
$1.57M
Shareholders Equity
$2.99M
Cash & Equivalents
$1.80M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-10.45M
CapEx
$24643
Free Cash Flow
$-10.48M
Profitability Metrics
Gross Margin
100.0%
Operating Margin
-72.6%
ROE
-1.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LEXX revenue?
LEXX's most recent quarterly revenue was $705923.00. Annual revenue can be calculated by summing the four most recent quarters.
Is LEXX profitable?
LEXX reported a loss of $11.90M in the most recent quarter.
What is LEXX market cap?
LEXX has a market capitalization of $24.42M, making it a small-cap stock.
Does LEXX have debt?
View LEXX's balance sheet for debt information.
What is LEXX cash flow?
LEXX's most recent quarterly free cash flow was $-10.48M.